Soleo Health selected by Genentech to provide two limited distribution drugs
McKINNEY, Texas — Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drugs, Hemlibra and Ocrevus. Hemlibra (emicizumab-kxwh), for patients with hemophilia A with factor VIII inhibitors, received approval from
